Clinical Trial Update: Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of HY07121 powder for infusion in patients with advanced solid tumors is ongoing, sponsored by Sichuan Huiyu Pharmaceutical Co., Ltd,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HY07121 (HY07121)

Snippet

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd | Conditions: Safety, Tolerability | Phase 1, Phase 2 | Status: RECRUITING